Jinqiu Zhao

870 total citations · 1 hit paper
34 papers, 573 citations indexed

About

Jinqiu Zhao is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Jinqiu Zhao has authored 34 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Jinqiu Zhao's work include Ginseng Biological Effects and Applications (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Liver physiology and pathology (3 papers). Jinqiu Zhao is often cited by papers focused on Ginseng Biological Effects and Applications (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Liver physiology and pathology (3 papers). Jinqiu Zhao collaborates with scholars based in China, United States and Germany. Jinqiu Zhao's co-authors include Yunsheng Ou, Wenxiang Huang, Shujun Zhang, Bin He, Bin He, Dianming Jiang, Cheng Yang, Yue Gao, Qing Xiao and Shi Chen and has published in prestigious journals such as Hepatology, Annals of Oncology and Frontiers in Immunology.

In The Last Decade

Jinqiu Zhao

34 papers receiving 562 citations

Hit Papers

T-cell exhaustion signatu... 2023 2026 2024 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinqiu Zhao China 15 198 131 100 83 79 34 573
Shihao Xu China 16 282 1.4× 105 0.8× 143 1.4× 68 0.8× 57 0.7× 51 725
Wenjiao Zeng China 13 228 1.2× 106 0.8× 61 0.6× 106 1.3× 58 0.7× 26 606
Suntrea T.G. Hammer United States 11 209 1.1× 118 0.9× 173 1.7× 96 1.2× 39 0.5× 34 602
Yunyun Luo Denmark 10 186 0.9× 82 0.6× 111 1.1× 40 0.5× 39 0.5× 23 645
Lingjian Zhang China 14 199 1.0× 161 1.2× 85 0.8× 51 0.6× 39 0.5× 37 565
Yingliang Wang China 13 150 0.8× 193 1.5× 115 1.1× 56 0.7× 21 0.3× 56 595
Lin Luo China 12 138 0.7× 47 0.4× 92 0.9× 74 0.9× 47 0.6× 28 510
Yu He China 13 153 0.8× 83 0.6× 89 0.9× 78 0.9× 31 0.4× 37 564
Liqun Li China 17 254 1.3× 70 0.5× 95 0.9× 116 1.4× 59 0.7× 73 733
Sanaz Keshavarz Shahbaz Iran 13 181 0.9× 60 0.5× 163 1.6× 51 0.6× 44 0.6× 32 634

Countries citing papers authored by Jinqiu Zhao

Since Specialization
Citations

This map shows the geographic impact of Jinqiu Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinqiu Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinqiu Zhao more than expected).

Fields of papers citing papers by Jinqiu Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinqiu Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinqiu Zhao. The network helps show where Jinqiu Zhao may publish in the future.

Co-authorship network of co-authors of Jinqiu Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Jinqiu Zhao. A scholar is included among the top collaborators of Jinqiu Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinqiu Zhao. Jinqiu Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liao, Wei‐Ting, Yi Zhang, Jingxiao Wang, et al.. (2025). β-Catenin regulates distinct pathways from YAP and suppresses ONECUT1 to drive hepatoblastoma development in mice and humans. Hepatology. 83(2). 215–230. 1 indexed citations
3.
Liu, Rong, Jing‐Wei Xu, Rongcheng Lin, et al.. (2024). 61O Updated results of a phase II trial evaluating an anti-EpCAM x anti-CD3 bispecific antibody, M701, for the treatment of malignant ascites. Annals of Oncology. 35. S1427–S1428. 3 indexed citations
4.
Chi, Hao, Songyun Zhao, Jinyan Yang, et al.. (2023). T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing. Frontiers in Immunology. 14. 1137025–1137025. 97 indexed citations breakdown →
5.
Zhao, Jinqiu, et al.. (2023). USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells. Cell Death and Disease. 14(1). 40–40. 19 indexed citations
6.
Zhong, Li, Jinqiu Zhao, Lu Huang, et al.. (2023). Runx2 activates hepatic stellate cells to promote liver fibrosis via transcriptionally regulating Itgav expression. Clinical and Translational Medicine. 13(7). e1316–e1316. 19 indexed citations
7.
Zhang, Chen, Jinqiu Zhao, Jie Zhao, et al.. (2022). CYP2E1-dependent upregulation of SIRT7 is response to alcohol mediated metastasis in hepatocellular carcinoma. Cancer Gene Therapy. 29(12). 1961–1974. 14 indexed citations
8.
Zhang, Ye, Bin He, Jinqiu Zhao, et al.. (2021). Addition of Celebrex and Pregabalin to Ropivacaine for Posterior Spinal Surgery: A Randomized, Double-Blinded, Placebo-Controlled Trial. Drug Design Development and Therapy. Volume 15. 735–742. 13 indexed citations
9.
He, Bin, Jinqiu Zhao, Lifeng Yin, et al.. (2021). Causal Effect of Serum Magnesium on Osteoporosis and Cardiometabolic Diseases. Frontiers in Nutrition. 8. 738000–738000. 14 indexed citations
10.
Yang, Cheng, Xiaoqing He, Jinqiu Zhao, & Wenxiang Huang. (2021). Hepatoprotection by Ginsenoside Rg1 in alcoholic liver disease. International Immunopharmacology. 92. 107327–107327. 25 indexed citations
11.
Chen, Ling, Jiao Li, Jinqiu Zhao, et al.. (2021). The genomic distribution map of human papillomavirus in Western China. Epidemiology and Infection. 149. e135–e135. 11 indexed citations
12.
He, Bin, et al.. (2020). Tranexamic Acid for Blood Loss after Transforaminal Posterior Lumbar Interbody Fusion Surgery: A Double‐Blind, Placebo‐Controlled, Randomized Study. BioMed Research International. 2020(1). 8516504–8516504. 14 indexed citations
13.
Zhao, Jinqiu, et al.. (2020). Potential risk factors for case fatality rate of novel coronavirus (COVID-19) in China: A pooled analysis of individual patient data. The American Journal of Emergency Medicine. 38(11). 2374–2380. 4 indexed citations
14.
Chen, Juanjuan, et al.. (2020). Clinical significance of serum human epididymis protein 4 in liver fibrosis. Medicine. 99(48). e23428–e23428. 6 indexed citations
15.
Gao, Yue, Shujun Zhang, Jiajun Li, et al.. (2020). Effect and mechanism of ginsenoside Rg1-regulating hepatic steatosis in HepG2 cells induced by free fatty acid. Bioscience Biotechnology and Biochemistry. 84(11). 2228–2240. 22 indexed citations
16.
Xiao, Qing, Shujun Zhang, Jiajun Li, et al.. (2020). Ginsenoside Rg1 alleviates ANIT-induced intrahepatic cholestasis in rats via activating farnesoid X receptor and regulating transporters and metabolic enzymes. Chemico-Biological Interactions. 324. 109062–109062. 13 indexed citations
17.
He, Bin, Jinqiu Zhao, Yunsheng Ou, & Dianming Jiang. (2018). Biofunctionalized peptide nanofiber-based composite scaffolds for bone regeneration. Materials Science and Engineering C. 90. 728–738. 29 indexed citations
18.
He, Bin, Yunsheng Ou, Ao Zhou, et al.. (2016). Functionalized D-form self-assembling peptide hydrogels for bone regeneration. Drug Design Development and Therapy. 10. 1379–1379. 37 indexed citations
19.
He, Bin, Yunsheng Ou, Shuo Chen, et al.. (2016). Designer bFGF-incorporated d -form self-assembly peptide nanofiber scaffolds to promote bone repair. Materials Science and Engineering C. 74. 451–458. 40 indexed citations
20.
Zhao, Jinqiu, et al.. (2014). Ginsenosides Rg1 from Panax ginseng: A Potential Therapy for Acute Liver Failure Patients?. Evidence-based Complementary and Alternative Medicine. 2014(1). 538059–538059. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026